Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066818

Chief Legal Officer gave up 854 shares (to pay taxes)

  • Chief Legal Officer acquired 2,808 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2017-12-15 Option exercise +1,733 78,438 D: show line 1 in the form
Ali-Jackson Kamil Chief Legal Officer 2017-12-15 Shares withheld for taxes −527 $24.23 $12,769 77,911 D: show line 2 in the form
Ali-Jackson Kamil Chief Legal Officer 2017-12-18 Option exercise +1,075 78,986 D: show line 3 in the form
Ali-Jackson Kamil Chief Legal Officer 2017-12-18 Shares withheld for taxes −327 $24.12 $7,887 78,659 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2017-12-15 Option exercise · Restricted Stock Units −1,733 12,133 D: show line 5 in the form
Ali-Jackson Kamil Chief Legal Officer 2017-12-18 Option exercise · Restricted Stock Units −1,075 2,150 D: show line 6 in the form
Loading xslF345X03/doc4.xml…